Page 2 - Xiaobin Wu News Today

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating)’s stock price traded down 3.1% on Tuesday . The stock traded as low as $212.34 and last traded at $215.03. 16,488 shares were traded during mid-day trading, a decline of 92% from the average session volume of 212,068 shares. The stock had previously closed at $221.84. Analyst Ratings Changes […]

StockNews.com assumed coverage on shares of BeiGene (NASDAQ:BGNE – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the stock. Several other equities research analysts have also weighed in on BGNE. Cowen lifted their price target on BeiGene from $213.00 to $262.00 and gave the company […]

StockNews.com assumed coverage on shares of BeiGene (NASDAQ:BGNE – Get Rating) in a report published on Thursday. The firm issued a hold rating on the stock. Several other brokerages have also issued reports on BGNE. Guggenheim reiterated a buy rating and issued a $350.00 price target on shares of BeiGene in a research note on […]

StockNews.com assumed coverage on shares of BeiGene (NASDAQ:BGNE – Get Rating) in a research note released on Thursday. The brokerage issued a hold rating on the stock. Other analysts also recently issued reports about the company. SVB Leerink upped their target price on BeiGene from $236.00 to $300.00 and gave the company an outperform rating […]

Prudential PLC lessened its position in shares of BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) by 45.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,616 shares of the company’s stock after selling 2,223 shares during the quarter. Prudential PLC’s holdings in BeiGene were […]

XY Capital Ltd bought a new position in BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 5,018 shares of the company’s stock, valued at approximately $1,104,000. BeiGene comprises about 0.7% of XY Capital Ltd’s holdings, making the stock its 23rd […]

Four new indications added for tislelizumab and all nine approved indications now included in NRDL KYPROLIS included for the first time XGEVA successfully renewed BeiGene (NASDAQ: BGNE; HKEX:

In an article published in the journal Sensors, researchers have designed a novel non-linear prior and developed a corresponding algorithm to help restore remote sensing images.

Equities analysts expect that BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) will report $312.21 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for BeiGene’s earnings, with the lowest sales estimate coming in at $307.52 million and the highest estimate coming in at $316.90 million. BeiGene posted sales of $149.99 million […]

Wall Street brokerages predict that BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) will post ($4.38) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for BeiGene’s earnings, with the lowest EPS estimate coming in at ($4.45) and the highest estimate coming in at ($4.30). BeiGene reported […]